Developing new drugs for Parkinson's disease
ALBANY MOLECULAR RESEARCH INC:1106422 [20-006949]
This study is working on developing new medications to help people with Parkinson's disease by creating and testing small compounds that could improve symptoms or slow down the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albany Molecular Research, INC. NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project ID | NIH-10285556 on NIH RePORTER |
What this research studies
This research focuses on creating new therapeutic compounds aimed at treating Parkinson's disease. It involves a comprehensive approach that includes designing and synthesizing small molecules, testing their absorption and metabolism, and evaluating their effectiveness as inhibitors of specific enzymes related to the disease. Patients may benefit from the development of novel drugs that could improve their symptoms or slow disease progression. The research utilizes advanced techniques in medicinal chemistry and biological assays to identify promising drug candidates.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease who are seeking new treatment options.
Not a fit: Patients who do not have Parkinson's disease or related neurological disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new medications that effectively treat Parkinson's disease.
How similar studies have performed: Previous research in medicinal chemistry has successfully led to the development of new treatments for neurological disorders, indicating a promising potential for this approach.
Where this research is happening
Albany, United States
- Albany Molecular Research, INC. — Albany, United States (Active)
Researchers
- Principal investigator: Allard, Melissa — Albany Molecular Research, INC.
- Study coordinator: Allard, Melissa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.